Hester Franckena

Hester Franckena conducted the landmark randomized trial demonstrating that adding deep regional hyperthermia to radiotherapy significantly improves local control and survival in locally advanced cervical cancer, establishing hyperthermia as a standard treatment option in the Netherlands. Her long-term follow-up data confirmed durable survival benefits with thermoradiotherapy at 12-year median follow-up. She is a leading clinical advocate for integrating hyperthermia into standard oncological practice.